Safety and efficacy of omalizumab for antihistamine-resistant chronic urticaria in children: a case series and literature review

World J Pediatr. 2024 Mar;20(3):294-298. doi: 10.1007/s12519-023-00760-4. Epub 2023 Sep 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Child
  • Chronic Urticaria* / drug therapy
  • Histamine Antagonists / pharmacology
  • Histamine H1 Antagonists
  • Humans
  • Omalizumab* / adverse effects
  • Treatment Outcome

Substances

  • Histamine Antagonists
  • Histamine H1 Antagonists
  • Omalizumab